KindredBio is a biotechnology company that develops medicines for pets. We believe that our animal family members deserve the same great medicines that human family members enjoy.
Stock InformationNASDAQ CM$7.35
Kindred Biosciences Announces Third Quarter 2017 Financial Results
November 7, 2017
SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce Third Quarter 2017 Financial Results
October 11, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference
October 5, 2017
SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...